ARMS-I (a Formulation of Cetylpyridinium Chloride -CPC)

NCT03026205 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Viral Upper Respiratory Tract Infection

Interventions

DRUG: ARMS-I

Sponsor

University of Toledo Health Science Campus

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]